PMID- 36531047 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20221221 IS - 2234-943X (Print) IS - 2234-943X (Electronic) IS - 2234-943X (Linking) VI - 12 DP - 2022 TI - Case Report: A novel LHFPL3::NTRK2 fusion in dysembryoplastic neuroepithelial tumor. PG - 1064817 LID - 10.3389/fonc.2022.1064817 [doi] LID - 1064817 AB - Neurotrophic tyrosine receptor kinase (NTRK) rearrangements are oncogenic drivers of various types of adult and pediatric tumors, including gliomas. However, NTRK rearrangements are extremely rare in glioneuronal tumors. Here, we report a novel NTRK2 rearrangement in a 24-year-old female with dysembryoplastic neuroepithelial tumor (DNT), a circumscribed WHO grade I benign tumor associated with epilepsy. By utilizing targeted RNA next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), reverse transcriptase PCR (RT-PCR), and Sanger sequencing, we verified an in-frame fusion between NTRK2 and the lipoma HMGIC fusion partner-like 3 (LHFPL3). This oncogenic gene rearrangement involves 5' LHFPL3 and 3' NTRK2, retaining the entire tyrosine kinase domain of NTRK2 genes. Moreover, the targeted DNA NGS analysis revealed an IDH1 (p.R132H) mutation, a surprising finding in this type of tumor. The pathogenic mechanism of the LHFPL3::NTRK2 in this case likely involves aberrant dimerization and constitutive activation of RTK signaling pathways. CI - Copyright (c) 2022 Chen, Zhu, Wang, Dai, Chen, Chen, Zhou, Dai, Zhao, Xiao and Lan. FAU - Chen, Yanming AU - Chen Y AD - Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China. FAU - Zhu, Qing AU - Zhu Q AD - Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China. FAU - Wang, Ye AU - Wang Y AD - Heath Management Center, The Second Affiliated Hospital of Soochow University, Suzhou, China. FAU - Dai, Xiaoxiao AU - Dai X AD - Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, China. FAU - Chen, Ping AU - Chen P AD - Molecular Genetics Laboratory, Suzhou Sano Precision Medicine Ltd., Suzhou, China. FAU - Chen, Ailin AU - Chen A AD - Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China. FAU - Zhou, Sujuan AU - Zhou S AD - Molecular Genetics Laboratory, Suzhou Sano Precision Medicine Ltd., Suzhou, China. AD - Pathology and Pathophysiology, Soochow University Medical College, Suzhou, China. FAU - Dai, Chungang AU - Dai C AD - Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China. FAU - Zhao, Shengbin AU - Zhao S AD - Molecular Genetics Laboratory, Suzhou Sano Precision Medicine Ltd., Suzhou, China. FAU - Xiao, Sheng AU - Xiao S AD - Department of Pathology, Brigham and Women's Hospital, Boston, BS, United States. FAU - Lan, Qing AU - Lan Q AD - Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China. LA - eng PT - Case Reports DEP - 20221201 PL - Switzerland TA - Front Oncol JT - Frontiers in oncology JID - 101568867 PMC - PMC9752035 OTO - NOTNLM OT - IDH1 OT - LHFPL3 OT - NTRK2 OT - dysembryoplastic neuroepithelial tumors OT - next-generation sequencing COIS- Authors PC, SuZ, and ShZ were employed by Suzhou Sano Precision Medicine Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/12/20 06:00 MHDA- 2022/12/20 06:01 PMCR- 2022/01/01 CRDT- 2022/12/19 03:43 PHST- 2022/10/08 00:00 [received] PHST- 2022/11/17 00:00 [accepted] PHST- 2022/12/19 03:43 [entrez] PHST- 2022/12/20 06:00 [pubmed] PHST- 2022/12/20 06:01 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fonc.2022.1064817 [doi] PST - epublish SO - Front Oncol. 2022 Dec 1;12:1064817. doi: 10.3389/fonc.2022.1064817. eCollection 2022.